Lipocine, Inc. (LPCN)
1.615
+0.08
(+5.56%)
USD |
NASDAQ |
Nov 06, 10:19
Lipocine Profit Margin (Quarterly) : -1.38K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.38K% |
| March 31, 2026 | -3.08K% |
| December 31, 2025 | -206.9% |
| September 30, 2025 | -2.78K% |
| June 30, 2025 | -354.2% |
| March 31, 2025 | -1.99K% |
| December 31, 2024 | 51.05% |
| September 30, 2024 | |
| June 30, 2024 | -3.42K% |
| March 31, 2024 | 46.13% |
| December 31, 2023 | -4.15K% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | -7.04K% |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -526.4% |
| Date | Value |
|---|---|
| March 31, 2022 | |
| December 31, 2021 | 78.48% |
| September 30, 2021 | -5.60K% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -1.85K% |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | -635.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 0.83% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 36.56% |
| Veru, Inc. | -- |
| Eli Lilly & Co. | 26.44% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -65.59% |
| Return on Assets | -58.76% |
| Return on Invested Capital | -65.59% |
| Gross Profit Margin (Quarterly) | 92.32% |
| Operating Margin (Quarterly) | -1.50K% |
| Return on Net Operating Assets | -11.37K% |